Wissenschaftliche Arbeiten

Uzm. Dr. Serkan Gülcü

12 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33060365 PMID 42346265 Frei zugänglicher VolltextQuelle: OpenAlex

  2. Prognostic Impact of Clinicopathological and Inflammatory Markers in Surgically Treated Pulmonary Invasive Mucinous Adenocarcinoma

    Seminars in Thoracic and Cardiovascular Surgery, 2026

    DOI 10.1053/j.semtcvs.2025.08.007 PMID 40975455 Quelle: ORCID

  3. Baseline vitamin D levels and progression-free survival in patients with HR+/HER2-metastatic breast cancer treated with ribociclib: a retrospective single-center analysis

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-05502-2 PMID 42340556 Frei zugänglicher VolltextQuelle: ORCID

  4. Investigation of systemic treatment responses and prognostic factors in metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs)

    Journal of Health Sciences and Medicine, 2025

    DOI 10.32322/jhsm.1744286 Frei zugänglicher VolltextQuelle: ORCID

  5. Prognostic Value of Inflammatory Markers, CA 19-9, MELD Score, and ECOG in Stage 4 Gastric Cancer with Liver Metastases

    Acta haematologica oncologica Turcica., 2025

    DOI 10.4274/ahot.galenos.2025.2025-5-4 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  6. Vitamin D Deficiency Predicts Poor Survival in CDK4/6 Inhibitor Treated HR+/HER2− Metastatic Breast Cancer

    SSRN Electronic Journal, 2025

    DOI 10.2139/ssrn.5600973 Frei zugänglicher VolltextQuelle: OpenAlex

  7. Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380 Frei zugänglicher VolltextQuelle: OpenAlex

  8. Garcinol (Garcinia Cambogia)

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380.c13895 Quelle: ORCID

  9. Clinicopathological and Demographics Analysis of Testicular Tumors: A Single-center Experience

    Acta haematologica oncologica Turcica., 2024

    DOI 10.4274/ahot.galenos.2024.95666 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  10. Anti-Neoplastik İlaçlar

    Akademisyen Kitabevi eBooks, 2023

    DOI 10.37609/akya.2429 Frei zugänglicher VolltextQuelle: ORCID

  11. Evaluation of Relapse Risk Factors and Treatment Outcomes in Stage 1 Germ Cell Testicular Tumors

    Dicle Medical Journal / Dicle Tip Dergisi, 2023

    DOI 10.5798/dicletip.1411488 Frei zugänglicher VolltextQuelle: OpenAlex

  12. Kronik Böbrek Hastalarının Geriatrik Nütrisyonel Risk İndeksi İle Değerlendirilmesi

    Batı Karadeniz Tıp Dergisi, 2022

    DOI 10.29058/mjwbs.1160225 Frei zugänglicher VolltextQuelle: ORCID